Thelma Therapeutics (XKRX:015540) Total Stockholders Equity : ₩10,535 Mil (As of Sep. 2022)

View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Total Stockholders Equity?

Thelma Therapeutics's Total Stockholders Equity for the quarter that ended in Sep. 2022 was ₩10,535 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Thelma Therapeutics's Book Value per Share for the quarter that ended in Sep. 2022 was ₩429.06. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Thelma Therapeutics's Debt-to-Equity for the quarter that ended in Sep. 2022 was 1.09.

Thelma Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Thelma Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Total Stockholders Equity Chart

Thelma Therapeutics Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Stockholders Equity

Get a 7-Day Free Trial

7,405.82

3,603.57

2,630.67

735.92

14,081.51

Thelma Therapeutics Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Stockholders Equity	Get a 7-Day Free Trial															-1,776.72	14,081.51	13,076.36	11,221.33	10,535.12

Thelma Therapeutics (XKRX:015540) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Thelma Therapeutics's Book Value per Share for the quarter that ended in Sep. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(10535.123	-	0.002)	/	24.5539
	=	429.06

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Thelma Therapeutics's Debt-to-Equity for the quarter that ended in Sep. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11478.959	+	0)	/	10535.123
	=	1.09

Thelma Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Thelma Therapeutics (XKRX:015540) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR

Website

http://www.medi-plant.co.kr

Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines